首页> 美国卫生研究院文献>Oncotarget >Loss of expression of the recycling receptor FcRn promotes tumor cell growth by increasing albumin consumption
【2h】

Loss of expression of the recycling receptor FcRn promotes tumor cell growth by increasing albumin consumption

机译:回收受体FcRn表达的丧失通过增加白蛋白消耗促进肿瘤细胞生长

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor cells rely on high concentrations of amino acids to support their growth and proliferation. Although increased macropinocytic uptake and lysosomal degradation of the most abundant serum protein, albumin, in Ras-transformed cells can meet these demands, it is not understood how the majority of tumor cells that express wild type Ras achieve this. In the current study we reveal that the neonatal Fc receptor, FcRn, regulates tumor cell proliferation through the ability to recycle its ligand, albumin. By contrast with normal epithelial cells, we show that human FcRn is present at very low or undetectable levels in the majority of tumor cell lines analyzed. Remarkably, shRNA-mediated ablation of FcRn expression in an FcRn-positive tumor cell line results in a substantial growth increase of tumor xenografts, whereas enforced expression of this receptor by lentiviral transduction has the reverse effect. Moreover, intracellular albumin and glutamate levels are increased by the loss of FcRn-mediated recycling of albumin, combined with hypoalbuminemia in tumor-bearing mice. These studies identify a novel role for FcRn as a suppressor of tumor growth and have implications for the use of this receptor as a prognostic indicator and therapeutic target.
机译:肿瘤细胞依靠高浓度的氨基酸来支持其生长和增殖。尽管在Ras转化的细胞中增加了最丰富的血清蛋白白蛋白的大粒细胞摄取和溶酶体降解,可以满足这些要求,但尚不清楚大多数表达野生型Ras的肿瘤细胞是如何实现这一目标的。在当前的研究中,我们揭示了新生儿Fc受体FcRn通过回收其配体白蛋白的能力来调节肿瘤细胞的增殖。与正常上皮细胞相比,我们显示在大多数分析的肿瘤细胞系中,人FcRn的含量非常低或无法检测。值得注意的是,shRNA介导的FcRn阳性肿瘤细胞系中FcRn表达的消融导致肿瘤异种移植物大量增加,而慢病毒转导的该受体表达的增强则具有相反的作用。此外,由于FcRn介导的白蛋白再循环的丧失,再加上荷瘤小鼠的低白蛋白血症,细胞内白蛋白和谷氨酸水平增加。这些研究确定了FcRn作为肿瘤生长抑制剂的新作用,并暗示了该受体作为预后指标和治疗靶标的用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号